Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

750 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Alcohol dose in septal ablation for hypertrophic obstructive cardiomyopathy.
Veselka J, Faber L, Liebregts M, Cooper R, Januska J, Kashtanov M, Dabrowski M, Hansen PR, Seggewiss H, Bonaventura J, Polakova E, Hansvenclova E, Bundgaard H, Ten Berg J, Stables RH, Jarkovsky J, Jensen MK. Veselka J, et al. Among authors: dabrowski m. Int J Cardiol. 2021 Jun 15;333:127-132. doi: 10.1016/j.ijcard.2021.02.056. Epub 2021 Feb 27. Int J Cardiol. 2021. PMID: 33647367 Free article.
Long term exercise capacity in patients with hypertrophic cardiomyopathy treated with percutaneous transluminal septal myocardial ablation.
Malek LA, Chojnowska L, Klopotowski M, Maczynska R, Demkow M, Witkowski A, Kusmierczyk B, Piotrowicz E, Konka M, Dabrowski M, Ruzyllo W. Malek LA, et al. Among authors: dabrowski m. Eur J Heart Fail. 2008 Nov;10(11):1123-6. doi: 10.1016/j.ejheart.2008.09.005. Epub 2008 Oct 7. Eur J Heart Fail. 2008. PMID: 18840395 Free article.
The risk of non-sustained ventricular tachycardia after percutaneous alcohol septal ablation in patients with hypertrophic obstructive cardiomyopathy.
Klopotowski M, Chojnowska L, Malek LA, Maczynska R, Kukula K, Demkow M, Witkowski A, Dabrowski M, Karcz M, Baranowski R, Kusmierczyk-Droszcz B, Kruk M, Jamiolkowski J, Kusmierczyk M, Szumowski L, Ruzyllo W. Klopotowski M, et al. Among authors: dabrowski m. Clin Res Cardiol. 2010 May;99(5):285-92. doi: 10.1007/s00392-010-0116-z. Epub 2010 Feb 11. Clin Res Cardiol. 2010. PMID: 20148331 Clinical Trial.
Early outcomes of alcohol septal ablation for hypertrophic obstructive cardiomyopathy: a European multicenter and multinational study.
Veselka J, Lawrenz T, Stellbrink C, Zemanek D, Branny M, Januska J, Sitar J, Dimitrow P, Krejci J, Dabrowski M, Mizera S, Bartel T, Kuhn H. Veselka J, et al. Among authors: dabrowski m. Catheter Cardiovasc Interv. 2014 Jul 1;84(1):101-7. doi: 10.1002/ccd.25236. Epub 2013 Nov 7. Catheter Cardiovasc Interv. 2014. PMID: 24285605 Clinical Trial.
Comparison of one- and 12-month outcomes of transcatheter aortic valve replacement in patients with severely stenotic bicuspid versus tricuspid aortic valves (results from a multicenter registry).
Kochman J, Huczek Z, Scisło P, Dabrowski M, Chmielak Z, Szymański P, Witkowski A, Parma R, Ochala A, Chodór P, Wilczek K, Reczuch KW, Kubler P, Rymuza B, Kołtowski L, Scibisz A, Wilimski R, Grube E, Opolski G. Kochman J, et al. Among authors: dabrowski m. Am J Cardiol. 2014 Sep 1;114(5):757-62. doi: 10.1016/j.amjcard.2014.05.063. Epub 2014 Jun 19. Am J Cardiol. 2014. PMID: 25037674 Clinical Trial.
The value of cardiac magnetic resonance and distribution of late gadolinium enhancement for risk stratification of sudden cardiac death in patients with hypertrophic cardiomyopathy.
Klopotowski M, Kukula K, Malek LA, Spiewak M, Polanska-Skrzypczyk M, Jamiolkowski J, Dabrowski M, Baranowski R, Klisiewicz A, Kusmierczyk M, Jasinska A, Jarmus E, Kruk M, Ruzyllo W, Witkowski A, Chojnowska L. Klopotowski M, et al. Among authors: dabrowski m. J Cardiol. 2016 Jul;68(1):49-56. doi: 10.1016/j.jjcc.2015.07.020. Epub 2015 Sep 9. J Cardiol. 2016. PMID: 26363820 Free article.
750 results